Logo image of PRNB

Principia Biopharma Inc (PRNB) Stock Fundamental Analysis

USA - NASDAQ:PRNB -

100.05
+0.1 (+0.1%)
Last: 9/25/2020, 8:00:02 PM
100.02
-0.03 (-0.03%)
After Hours: 9/25/2020, 8:00:02 PM
No Fundamental Analysis report for PRNB not available.

Principia Biopharma Inc

NASDAQ:PRNB (9/25/2020, 8:00:02 PM)

After market: 100.02 -0.03 (-0.03%)

100.05

+0.1 (+0.1%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.02%
Inst Owner Change0%
Ins Owners6.47%
Ins Owner Change0%
Market Cap3.32B
Revenue(TTM)50.00M
Net Income(TTM)-68.91M
Analysts82.8
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 66.45
P/FCF N/A
P/OCF N/A
P/B 9.45
P/tB N/A
EV/EBITDA -41.07
EPS(TTM)-2.41
EYN/A
EPS(NY)-4.82
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS1.51
BVpS10.58
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -17.85%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM -148.35%
PM (TTM) -137.82%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y0%
ROICexgc growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score1
Asset Turnover0.13
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 17.01
Quick Ratio 17.01
Altman-Z 57.63
F-Score1
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-3112.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%10.71%
EPS Next Y-33.49%
EPS Next 2Y-53.13%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-37.39%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%66.67%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

Principia Biopharma Inc / PRNB FAQ

What is the ChartMill fundamental rating of Principia Biopharma Inc (PRNB) stock?

ChartMill assigns a fundamental rating of 3 / 10 to PRNB.


Can you provide the valuation status for Principia Biopharma Inc?

ChartMill assigns a valuation rating of 1 / 10 to Principia Biopharma Inc (PRNB). This can be considered as Overvalued.


Can you provide the profitability details for Principia Biopharma Inc?

Principia Biopharma Inc (PRNB) has a profitability rating of 2 / 10.


Can you provide the financial health for PRNB stock?

The financial health rating of Principia Biopharma Inc (PRNB) is 8 / 10.


Can you provide the dividend sustainability for PRNB stock?

The dividend rating of Principia Biopharma Inc (PRNB) is 0 / 10 and the dividend payout ratio is 0%.